Sepsis, a serious and often fatal complication of infection, is the leading cause of both ALI and acute respiratory distress syndrome (ARDS). These conditions, which are associated with high mortality rates, remain difficult to treat due to the lack of effective treatments. NETs play a central role in the progression of sepsis, as they are involved in trapping pathogens, but they can also cause excessive inflammation, exacerbating lung injury. The complexity of sepsis-induced ALI, due to the interplay between inflammation, immune dysregulation, and coagulation, requires innovative therapeutic strategies to better manage this critical condition.
In a study (DOI: 10.7555/JBR.38.20240038) from Nanjing Medical University, researchers have made significant progress in this area. Posted on Journal of Biomedical ResearchNov 28, 2024 The study details how medical ozone therapy targets the AMPK/SR-A1 axis to effectively clear NETs, significantly improving survival rates and lung function in mice suffering from sepsis-induced ALI. This work represents a critical step forward in the search for new treatments for this deadly condition.
The study provides an in-depth examination of the mechanisms behind the therapeutic effects of ozone therapy in sepsis-induced ALI. The researchers found that ozone treatment reduced the formation of NETs, which was a key factor in the development of ALI. By activating the AMPK/SR-A1 pathway, ozone therapy enhanced the ability of macrophages to clear these harmful NETs, reducing inflammation and mitigating lung injury. The research also highlights the essential role of SR-A1: in knockout mice lacking SR-A1, ozone therapy failed to produce its protective effects, highlighting the critical role of the receptor in mediating the therapeutic effect of ozone. A comprehensive assessment of pulmonary function, blood flow, and protein levels further demonstrated the multifaceted benefits of ozone therapy, suggesting that it could be a valuable addition to existing therapies for sepsis-induced ALI.
Dr. Wen-Tao Liu, the study’s principal investigator, underscores the importance of these findings: Our research shows that medical ozone therapy could dramatically improve the management of ALI caused by sepsis. By activating the AMPK/SR-A1 pathway, ozone therapy clears harmful NETs, restores immune balance, and reduces inflammation. This represents a promising new approach to critical care that could lead to better outcomes for patients suffering from sepsis.
The implications of this study are far-reaching. If further research confirms these results in human trials, medical ozone therapy could become a viable and effective treatment for lung injury caused by sepsis, a condition with few treatment options currently. The potential for ozone therapy to improve survival and lung function could transform the management of sepsis, offering new hope to patients facing a dismal prognosis. As this promising treatment progresses through further research, it may become a cornerstone in the battle against sepsis, reshaping the way we treat this life-threatening condition.
Source:
